VITURA HEALTH LIMITED (VIT)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

VIT - VITURA HEALTH LIMITED
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.06
Index: ALL-ORDS
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.32
25 Sep |
OPEN $0.32 |
HIGH $0.33 |
48,831 LOW $0.32 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 2.5 | 3.0 | xxx |
DPS (cps) | xxx | 1.0 | 1.0 | xxx |
EPS Growth | xxx | 99.2% | 20.5% | xxx |
DPS Growth | xxx | 0.0% | 0.0% | xxx |
PE Ratio | xxx | N/A | 10.7 | xxx |
Dividend Yield | xxx | N/A | 3.1% | xxx |
Div Pay Ratio(%) | xxx | 40.2% | 33.3% | xxx |
Last ex-div: 04/09 - ex-div 1c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 2.5 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 117.3 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 6.3 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 9.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 11.77 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 45.22 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 41.41 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 30.77 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 45.22 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 59.02 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 3.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 19 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 8.19 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross

Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 0.9 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.79 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 91 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 6 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
VIT STOCK CHART

FNArena News on VIT
1 |
FNArena Corporate Results Monitor – 25-08-2023Aug 25 2023 - Australia |
2 |
Breaking Boundaries: Medical PsychedelicsAug 21 2023 - Small Caps |
3 |
Australian Broker Call *Extra* Edition – Jul 03, 2023Jul 03 2023 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – Jun 07, 2023Jun 07 2023 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Feb 22, 2023Feb 22 2023 - Daily Market Reports |